Fresenius SE & Co. KGaA (FRE.DE) is in Healthcare, Medical Care Facilities, based in Germany, listed on XETRA. Market cap 23.97B EUR. 52-week range 35.11 to 52.96 EUR. Trailing P/E 16.0. Data as of 2026-10-09.
Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients in North America, Europe, the Asia-Pacific, Latin America, and Africa. It operates through Fresenius Kabi and Fresenius Helios segments. The Fresenius Kabi segment offers products for therapy and care of critically and chronically ill patients, including biopharmaceuticals, clinical nutrition, MedTech products, intravenously administered generic drugs, and IV fluids. It also provides ...